Caris Life Sciences, Inc. (CAI)
25.76
+0.28
(+1.12%)
USD |
NASDAQ |
Jan 22, 15:16
Caris Life Sciences EPS Diluted (Quarterly): 0.0862 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| TransMedics Group, Inc. | 0.6601 |
| AbbVie, Inc. | 0.0993 |
| BioLife Solutions, Inc. | 0.0127 |
| Phibro Animal Health Corp. | 0.649 |
| GeneDx Holdings Corp. | -0.2651 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 24.32M |
| Revenue (Quarterly) | 216.83M |
| Total Expenses (Quarterly) | 192.51M |
| Enterprise Value | 6.836B |
| Gross Profit Margin (Quarterly) | 68.03% |
| Profit Margin (Quarterly) | 11.22% |
| Earnings Yield | -9.42% |
| Normalized Earnings Yield | -8.857 |